Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream (4%, 6%, 8%) for the Treatment of Presbyopia
Status:
Not yet recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
This is a Multicenter, Randomized, Double-Masked Placebo-Controlled, Parallel Group Phase 2
Trial Evaluating the Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the
Treatment of Presbyopia.